Due to health issues, this site is no longer maintained and will be shut down shortly. |
Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders.
Their auditors issued a going concern opinion on their December 31, 2019 financial statements, expressing substantial doubt that they could continue as an ongoing business for the next twelve months.
$0.35 -0.03 (-7.85%)
As of 03/24/2023 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.